Vaccinex, Inc. SEC filings VCNX
Vaccinex, Inc. has 475 filings in SEC EDGAR's recent list, going back to Nov 12, 2002. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Mar 19, 2025 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Mar 19, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Mar 7, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Dec 17, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 14, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 9, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 19, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Other events
|
Aug 20, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Other events
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 12, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Apr 1, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 15, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Feb 13, 2024 | Feb 8, 2024 |
| 8-K/A | Amended current report | Feb 8, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 7, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Oct 13, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 22, 2023 | Sep 20, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 13, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 22, 2023 | Aug 18, 2023 |
| 8-K |
Current report
Listing notice
|
May 30, 2023 | May 25, 2023 |
| 8-K |
Current report
Other events
|
May 19, 2023 | May 19, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 15, 2023 | May 12, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2023 | May 11, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 23, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 25, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 11, 2022 | Oct 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Other events
|
Aug 8, 2022 | Aug 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 1, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2022 | May 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 31, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Other events
|
Jan 26, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Agreement ended
|
Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 17, 2021 | May 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2021 | May 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Other events
|
Feb 19, 2021 | Feb 19, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 9, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 26, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Other events
|
Sep 22, 2020 | Sep 17, 2020 |
| 8-K |
Current report
Other events
|
Sep 9, 2020 | Sep 9, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Other events
|
Aug 14, 2020 | Aug 14, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 31, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 10, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 18, 2020 | May 14, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 27, 2020 | Mar 27, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 23, 2020 | Jan 21, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 31, 2019 | Jul 26, 2019 |
| 8-K |
Current report
Listing notice
|
Jul 19, 2019 | Jul 15, 2019 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2019 | May 14, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2019 | Mar 18, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2019 | Mar 5, 2019 |
| 8-K |
Current report
Change to shareholder rights, Other events
|
Mar 4, 2019 | Mar 4, 2019 |
| 8-K |
Current report
Other events
|
Jan 24, 2019 | Jan 23, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2018 | Sep 26, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 13, 2018 | Aug 13, 2018 |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCNX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1205922
- Former names
- VACCINEX INC (until May 9, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.